| 摘要 |
biotechnology. SUBSTANCE: erythropoietin analogs include at least one supplementary site for glycosylation or at least one rearranged site for glycosylation and also DNA encoding indicated analogues. EFFECT: imparted therapeutic activity to claimed erythropoietin analogue forms containing some amount of sialic acid. 14 cl, 19 dwg, 10 tbl
|
